Form 4: Viemed Healthcare's Chief Medical Officer Reports Stock Transactions
SEC Form 4 Filing
Chief Medical Officer William Frazier reports the vesting of restricted stock units and subsequent tax withholding of shares.
Summary
- On August 25, 2024, William Frazier, Chief Medical Officer of Viemed Healthcare, Inc., reported transactions involving common shares and restricted stock units (RSUs).
- Frazier vested 3,594 restricted stock units, each representing a contingent right to receive one common share.
- The company withheld 876 shares to satisfy Frazier's tax obligations resulting from the vesting of the RSUs at a price of $7.39 per share.
- Following these transactions, Frazier directly owns 67,808 common shares.
Sentiment
Score: 5
Explanation: This is a neutral filing related to standard executive compensation practices; it doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minor impact on the total number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 08/25/2023 | Reporting person was granted Restricted Stock Units which vest on August 25, 2024. |
| 08/23/2025 | Date used to calculate per share value for tax withholding. |
| 08/25/2024 | Date of RSU vesting and share transactions. |
| 08/26/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.